Depression, Anxiety and Stress among COPD Patients: A Comparative Cross Sectional Study (original) (raw)
Related papers
International Journal of Advanced and Integrated Medical Sciences
Introduction Chronic disease like chronic obstructive pulmonary disease (COPD) is associated with various comorbidities. Anxiety and depression are among the common comorbidities and have significant impact on socioeconomic status of the person as well as the course of disease. In our study, we screened COPD patients attending the outpatient department (OPD) of pulmonary medicine for anxiety and depression, using different scales that include questionnaires. About 46.2 and 34.6% cases were found to have depression and anxiety respectively, among all COPD patients (n = 156). Incidence of anxiety and depression was directly proportional to severity of disease. Age, gender, locality, educational, marital, and socioeconomic statuses are some factors that play important roles in the development of these psychiatric comorbidities. Hence, mental assessment of COPD patients should be mandatory with every visit to the OPD. How to cite this article Jaiswal A, Kumar A, Rathi H, Sharma CS, Shar...
International journal of scientific research, 2019
Background: The aim of the study was to find the prevalence of anxiety and depression in COPD patients as undiagnosed cases may have an negative impact on the overall health status and find its correlation with factors like age, gender, disease severity and health related Quality of Life (QOL). Method: 226 subjects enrolled in this study. Basic demographic details were gathered. Hospital Anxiety and Depression Scale (HADS) was used to assess anxiety and depression. QOL was assessed using St. George's Respiratory Questionnaire (SGRQ). Result: Prevalence of anxiety and depression in COPD subjects in the study was 35.4% and 52.7% as per HADS questionnaire. Age and SGRQ score showed a significant positive correlation whereas disease severity showed a significant negative correlation with anxiety and depression. Association of the anxiety and depression with gender showed anxiety to be statistically significant in males and females. Conclusion: Higher rates of depression and anxiety symptoms are seen in patients with COPD even in earlier stages of the disease.
Journal of clinical and diagnostic research : JCDR, 2017
Anxiety and depression are important but often under-diagnosed co-morbid conditions in patients with Chronic Obstructive Pulmonary Disease (COPD) which may affect the functional capacity of the patients. To find out the proportion of depression and anxiety among stable COPD patients using a validated questionnaire suitable for use in clinic and the factors affecting their reduced functional capability as assessed by six-minute walk test. This was a descriptive cross-sectional study. Seventy five patients diagnosed with stable COPD in outpatient Department of Pulmonary Medicine in a tertiary care hospital, satisfying all inclusion criteria, were included in the study. They were examined clinically, categorized as per Global Initiative for Chronic Obstructive Lung Disease (GOLD) severity assessment guideline and interviewed by designated interviewer using validated questionnaire for depression (Hamilton depression rating scale, HAM-D) and anxiety (State Trait Anxiety Inventory, STAI)....
Anxiety and depression-Important psychological comorbidities of COPD
Journal of thoracic disease, 2014
Anxiety and depression are common and important comorbidities in patients with chronic obstructive pulmonary disease (COPD). The pathophysiology of these psychological comorbidities in COPD is complex and possibly explained by common risk factors, response to symptomatology and biochemical alterations. The presence of anxiety and/or depression in COPD patients is associated with increased mortality, exacerbation rates, length of hospital stay, and decreased quality of life and functional status. There is currently no consensus on the most appropriate approach to screening for anxiety and depression in COPD. Treatment options include psychological [relaxation, cognitive behavioural therapy (CBT), self-management] and pharmacological interventions. Although there is some evidence to support these treatments in COPD, the data are limited and mainly comprised by small studies. Pulmonary rehabilitation improves anxiety and depression, and conversely these conditions impact rehabilitation...
Factors affecting health status in COPD patients with co-morbid anxiety or depression
International journal of chronic obstructive pulmonary disease, 2007
Health status questionnaires provide standardized measures of patients' perceptions of the impact of disease on their daily life and well-being. Factors associated with health status were examined in a sample of 58 outpatients with chronic obstructive pulmonary disease (COPD) and co-morbid anxiety and/or depression. A cross-sectional descriptive study was conducted with the following measures: The St. George's Respiratory Questionnaire (SGRQ); the Beck Anxiety Inventory (BAI); the Beck Depression Inventory, 2nd edition (BDI); the Pittsburgh Sleep Quality Index (PSQI); and spirometry. Disease severity as measured with spirometrywas not related to health status. Perceptions of poor health as implied by the health status scores were positively associated with symptoms of anxiety and depression, sleep disturbances, and level of daily functioning. There were statistically significant differences between men and women on COPD severity, age, and the BAI scores. The findings emphasi...
2014
AbstractIntroduction: Previous research showed that comorbidities that are common in patients with Chronic Obstructive Pulmonary Disease (COPD) are anxiety and depression. Furthermore, stress can be associated with more depressive symptoms. Patients suffering from depression along with an additional medical condition, tend to have more severe symptoms in both depression and their medical illness. Aim: The aim of this study was to investigate depression, anxiety, and stress among COPD patients, and also to examine if there was a difference in levels of depression, anxiety and stress between genders, and between COPD patients and patients with COPD together with comorbid chronic condition. Method: This study had a descriptive and cross-sectional design with a quantitative method. The data collection took place at a respiratory ward at Cho Ray Hospital in Ho Chi Minh City, Vietnam. Sixty two COPD patients, both men and women, participated voluntarily by answering a questionnaire. Virgi...
International Journal of Nursing Knowledge, 2015
The aim of this study was to develop the Arabic version of the Hospital Anxiety and Depression Scale (A-HADS) and test its psychometric proprieties for the assessment of anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). METHOD: The A-HADS and Quality of Life Index Pulmonary version were completed by 67 Jordanian patients with COPD. RESULTS: Cronbach's alpha coefficient has been found to be 0.75 for the A-HADS anxiety subscale and 0.82 for the A-HADS depression subscale. A-HADS scores correlated significantly with the Quality of Life Index Pulmonary version and demonstrated construct validity. IMPLICATIONS: This preliminary validation study supports the A-HADS as a reliable and valid instrument for the assessment of anxiety and depression in Arabic speaking patients with COPD. Chronic obstructive pulmonary disease (COPD) is expected to be the third leading cause of death in middleincome countries by 2030 (Russell, Anzueto, & Weisman, 2011). The negative impact of COPD can be further complicated by the presence of psychological comorbidity in patients with COPD. It is well established that anxiety and depression are the most common psychological disorders of patients with COPD (
PREVALENCE OF ANXIETY AND DEPRESSION IN STABLE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
National Journal of Medical Research, 2021
Introduction: To study the prevalence of anxiety and depression in stable COPD patients. Methodology: 100patients of stable COPD were assessed to look for the presence of anxiety and depression using beck anxiety inventory (BAI) and patient health questionnaire (PHQ-9). Patients already on treatment forpsychiatric illnesses were excluded from the study. Patients with total score above cut off value (BAI >7 ORPHQ-9 >4), were assessed in the psychiatry department. Quantitative data was compiled and statistical analysis was done. Results: Among study population 68% were males, 62% were in the age group of 60-80years, 83 % were ex smokers and 92 % of them were exposed to indoor air pollution (chullahs). It was found that 64 % of the study population had psychiatric morbidity out of which 42% had mixed anxiety and depressive symptoms. Psychiatric symptoms were more prevalent in female patients (97%, P value is0.003), and in patients who had more severe disease (P value is 0.04), 6 minute walk distance < 300 m (P value is 0.00001), percentage of desaturatoin> 3% after 6 M.W (P value is 0.0001) and Smoking Index >400.Smoking status and 6 minute walk distance were independently associated with the development of anxiety and depression with significant P values in stable COPD patients. Conclusion: Anxiety and depression are common psychiatric co-morbidities associated with COPD patients. Early diagnosis and proper management of COPD and timely evaluation for psychiatric illnesses is essential for the better outcomes in COPD patients.
Symptoms of anxiety and depression in patients with chronic obstructive pulmonary disease
Despite the prevalence and importance of anxiety and depressive symptoms in chronic obstructive pulmonary disease (COPD) patients, procedures for routine screening in therapeutic protocols are not commonly used. to assess the symptoms of anxiety and depression in COPD patients and to evaluate their relation to patients' demographic parameters and clinical characteristics. The research included 40 COPD patients, treated at the Institute of Lung Diseases and Tuberculosis, Clinical Centre Serbia in Belgrade, from November 2010 to February 2011. Study data were assessed by the questionnaire designed for the purposes of the present study together with Hamilton Anxiety Rating Scale (HARS) and Hamilton Depression Rating Scale (HDRS). Mean HARS score was 10.7 (SD=6.5) (22.5% subjects scored > or = 17) and mean HDRS score was 10.7 (SD=8.2) (20.0% subjects scored > or = 17). Depression was significantly higher in women (Z=-1.971: p=0.049). Lower value of forced expiratory volume in ...